TCL Archive Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees January 6, 1984
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy May 20, 1994
TCL Archive In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit December 18, 2009
TCL Archive NCI director creates four new deputy director positions to manage the Institute. February 20, 2004
